Aberdeen Group
XRAY icon

Aberdeen Group’s Dentsply Sirona XRAY Stock Holding History

Aberdeen Group’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,512
Closed -$1.34M – 977
2024
Q1 		$1.34M Sell
40,512
-70,982
-64% -$2.43M ﹤0.01% 807
2023
Q4 		$3.97M Buy
111,494
+31,852
+40% +$1.01M 0.01% 710
2023
Q3 		$2.72M Sell
79,642
-3,687
-4% -$140K 0.01% 652
2023
Q2 		$3.33M Buy
83,329
+27,628
+50% +$1.1M 0.01% 640
2023
Q1 		$2.19M Buy
55,701
+114
+0.2% +$4.18K 0.01% 711
2022
Q4 		$1.77M Sell
55,587
-116,022
-68% -$3.5M ﹤0.01% 717
2022
Q3 		$4.87M Buy
171,609
+79,559
+86% +$2.72M 0.01% 558
2022
Q2 		$3.31M Buy
92,050
+8,982
+11% +$363K 0.01% 636
2022
Q1 		$4.14M Buy
83,068
+661
+0.8% +$34.9K 0.01% 622
2021
Q4 		$4.6M Sell
82,407
-14,858
-15% -$817K 0.01% 651
2021
Q3 		$5.67M Buy
97,265
+21,111
+28% +$1.3M 0.01% 629
2021
Q2 		$4.82M Sell
76,154
-6,966
-8% -$459K 0.01% 655
2021
Q1 		$5.3M Buy
83,120
+4,028
+5% +$234K 0.01% 634
2020
Q4 		$4.14M Buy
79,092
+5,627
+8% +$278K 0.01% 645
2020
Q3 		$3.21M Sell
73,465
-36,145
-33% -$1.6M 0.01% 644
2020
Q2 		$4.83M Sell
109,610
-13,436
-11% -$568K 0.01% 554
2020
Q1 		$4.78M Sell
123,046
-4,272
-3% -$218K 0.02% 525
2019
Q4 		$7.2M Buy
127,318
+26,251
+26% +$1.46M 0.02% 527
2019
Q3 		$5.39M Sell
101,067
-1,553
-2% -$83.4K 0.01% 578
2019
Q2 		$5.99M Sell
102,620
-1,931
-2% -$104K 0.01% 602
2019
Q1 		$5.18M Buy
104,551
+30,039
+40% +$1.32M 0.01% 625
2018
Q4 		$2.77M Buy
74,512
+2,195
+3% +$79.9K 0.01% 651
2018
Q3 		$2.73M Buy
72,317
+11,080
+18% +$461K 0.01% 709
2018
Q2 		$2.68M Buy
61,237
+17,176
+39% +$807K 0.01% 694
2018
Q1 		$2.22M Buy
44,061
+2,815
+7% +$166K ﹤0.01% 651
2017
Q4 		$2.71M Buy
41,246
+654
+2% +$41.6K 0.01% 635
2017
Q3 		$2.43M Buy
+40,592
New +$2.41M ﹤0.01% 627

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $588M AUM 6.93% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aberdeen Group's XRAY Position: Q2 2024 in Review

Aberdeen Group sold out of Dentsply Sirona (XRAY) in Q2 2024, closing a stake of 40,512 shares — an estimated $1.34M sold.

Aberdeen Group first reported a position in XRAY in Q3 2017 and held it in 27 quarters. The position peaked at $7.2M in Q4 2019. 381 funds tracked by Wall St. Rank hold XRAY as of Q2 2024.

  • Aberdeen Group reported no remaining Dentsply Sirona position as of Q2 2024 after selling out during the quarter.
  • Aberdeen Group sold 40,512 Dentsply Sirona shares in Q2 2024, an estimated $1.34M.
  • Aberdeen Group first reported a position in Dentsply Sirona in Q3 2017 and held it in 27 quarters.
  • Aberdeen Group's Dentsply Sirona position peaked at $7.2M in Q4 2019.
  • 381 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2024.

Based on Aberdeen Group's 13F filing for Q2 2024, filed 9 Aug 2024.